Show simple item record

dc.contributor.authorOpollo, VSen
dc.contributor.authorNikuze, Aen
dc.contributor.authorBen-Farhat, Jen
dc.contributor.authorAnyango, Een
dc.contributor.authorHumwa, Fen
dc.contributor.authorOyaro, Ben
dc.contributor.authorWanjala, Sen
dc.contributor.authorOmwoyo, Wen
dc.contributor.authorMajiwa, Men
dc.contributor.authorAkelo, Ven
dc.contributor.authorZeh, Cen
dc.contributor.authorMaman, Den
dc.date.accessioned2019-02-14T14:35:07Z
dc.date.available2019-02-14T14:35:07Z
dc.date.issued2018-12-27
dc.date.submitted2019-02-01
dc.identifier.citationField evaluation of near point of care Cepheid GeneXpert HIV-1 Qual for early infant diagnosis. 2018, 13 (12):e0209778 PLoS ONEen
dc.identifier.issn1932-6203
dc.identifier.pmid30589900
dc.identifier.doi10.1371/journal.pone.0209778
dc.identifier.urihttp://hdl.handle.net/10144/619337
dc.description.abstractAccess to point-of-care HIV testing shortens turn-around times, time to diagnosis and reduces loss to follow-up hence minimizing barriers to early linkage to care and treatment among HIV infected infants. Currently samples for early infant HIV diagnosis are sent to centralized testing facilities which are few and located only at specific regions in Kenya. However, there are Point of Care (POC) early infant diagnosis [EID] technologies elsewhere such as SAMBA and ALERE-Q that are yet to be evaluated in Kenya despite the urgent need for data to inform policy formulation regarding EID. The Cepheid GeneXpert HIV-1 Qual (GeneXpert) technology for POC EID offers a great opportunity to minimize HIV associated morbidity, mortality and loss to follow-up through decentralization of early infant HIV testing to the clinics. This technology also allows for same-day results thus facilitating prompt linkage to care.
dc.language.isoenen
dc.publisherPublic Library of Scienceen
dc.rightsPublished by Public Library of Scienceen
dc.titleField Evaluation of Near Point of Care Cepheid GeneXpert HIV-1 Qual for Early Infant Diagnosisen
dc.identifier.journalPloS oneen
refterms.dateFOA2019-03-04T14:18:39Z
html.description.abstractAccess to point-of-care HIV testing shortens turn-around times, time to diagnosis and reduces loss to follow-up hence minimizing barriers to early linkage to care and treatment among HIV infected infants. Currently samples for early infant HIV diagnosis are sent to centralized testing facilities which are few and located only at specific regions in Kenya. However, there are Point of Care (POC) early infant diagnosis [EID] technologies elsewhere such as SAMBA and ALERE-Q that are yet to be evaluated in Kenya despite the urgent need for data to inform policy formulation regarding EID. The Cepheid GeneXpert HIV-1 Qual (GeneXpert) technology for POC EID offers a great opportunity to minimize HIV associated morbidity, mortality and loss to follow-up through decentralization of early infant HIV testing to the clinics. This technology also allows for same-day results thus facilitating prompt linkage to care.


Files in this item

Thumbnail
Name:
Opollo et al - 2019 - Field ...
Size:
917.6Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record